Xiangchen Cui

Xiangchen Cui currently serves as Senior Director and Head of Statistical Programming at CRISPR Therapeutics, responsible for establishing the Statistical Programming Department and supporting ongoing clinical studies. Prior to this role, Xiangchen held multiple senior leadership positions at Alkermes, leading successful clinical development efforts that resulted in three FDA approvals, and at Vertex Pharmaceuticals, where Xiangchen led teams for significant submissions that achieved rapid approvals. Xiangchen’s experience includes positions at Sanofi-Aventis, GlaxoSmithKline, and Merck & Co., focusing on statistical programming and regulatory submissions for various therapeutic areas. Xiangchen holds a Ph.D. in Statistics from Utah State University and a Master's degree in Applied Mathematics from the University of Science and Technology Beijing.